Disseminated Coccidioidomycosis Following Insufficient Treatment at Initial Presentation: Case Report
- PMID: 32806960
- PMCID: PMC7436796
- DOI: 10.1177/2324709620949315
Disseminated Coccidioidomycosis Following Insufficient Treatment at Initial Presentation: Case Report
Abstract
A 35-year-old male presented to our university hospital with night sweats, fevers, ulcerated skin lesions to the lower mouth and posterior neck, shortness of breath, and an enlarging cervical lymph node. The patient was evaluated 2 months prior for respiratory symptoms, cervical lymphadenopathy, and skin lesions resulting in a diagnosis of primary pulmonary coccidioidomycosis and was treated with a 4-week course of fluconazole. On presentation to our hospital, initial laboratory test results revealed leukocytosis, increased liver enzymes, elevated inflammatory markers, and hypercalcemia. Computed tomography scan of the chest revealed lung nodules in a miliary pattern and prominent mediastinal lymphadenopathy. Magnetic resonance imaging revealed multiple vertebral and iliac bone lesions, as well as bilateral psoas muscle lesions. Serum ELISA (enzyme linked immunosorbent assay) detected elevated serological markers against coccidioides, and sputum culture revealed coccidioides arthroconidia, confirming the presence of an acute coccidioides infection. Biopsy of the right iliac crest and cervical lymph node revealed spherules resembling coccidioides, escalating the diagnosis to disseminated coccidioidomycosis. The patient's hospital course was complicated by septic shock, acute respiratory distress syndrome requiring several days of mechanical ventilation, and acute kidney injury. He was ultimately treated with several weeks of voriconazole and liposomal amphotericin-B. He made a full recovery and was discharged on an extended course of oral voriconazole. Our case highlights the importance of recognition and appropriate treatment duration of disseminated coccidioidomycosis at initial presentation. Failure to do so may lead to increased morbidity and mortality.
Keywords: disseminated coccidioidomycosis; insufficient treatment; pulmonary coccidioidomycosis; valley fever.
Conflict of interest statement
Figures




Similar articles
-
Pulmonary coccidioidomycosis after a renal transplant in a nonendemic region.Exp Clin Transplant. 2014 Feb;12(1):71-3. doi: 10.6002/ect.2012.0254. Epub 2013 Jun 5. Exp Clin Transplant. 2014. PMID: 23742155
-
Primary pulmonary coccidioidomycosis in China.Respirology. 2010 May;15(4):722-5. doi: 10.1111/j.1440-1843.2010.01747.x. Epub 2010 Apr 7. Respirology. 2010. PMID: 20409030
-
Septic shock in coccidioidomycosis.Crit Care Med. 1998 Jan;26(1):62-5. doi: 10.1097/00003246-199801000-00017. Crit Care Med. 1998. PMID: 9428544
-
Peritoneal Coccidioidomycosis: a Rare Case Report and Review of the Literature.J Gastrointestin Liver Dis. 2015 Dec;24(4):527-30. doi: 10.15403/jgld.2014.1121.244.coc. J Gastrointestin Liver Dis. 2015. PMID: 26697582 Review.
-
Pulmonary coccidioidomycosis.Semin Respir Crit Care Med. 2011 Dec;32(6):754-63. doi: 10.1055/s-0031-1295723. Epub 2011 Dec 13. Semin Respir Crit Care Med. 2011. PMID: 22167403 Review.
Cited by
-
Disseminated coccidioidomycosis in immunocompetent patients in non-endemic areas: a case series and literature review.Eur J Clin Microbiol Infect Dis. 2022 Jun;41(6):925-939. doi: 10.1007/s10096-022-04447-y. Epub 2022 May 12. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35546215 Review.
References
-
- Akram SM, Koirala J. Coccidioidomycosis. StatPearls; 2020. Accessed May 10, 2009 https://www.ncbi.nlm.nih.gov/books/NBK448161/
-
- Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63:e112-e146. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical